Transparency data

CMA board extraordinary meeting minutes: 5 February 2024

Published 3 June 2024

Meeting date: 5 February 2024

Venue: In the Cabot, London, and by videoconference

Members present

  • Marcus Bokkerink (Chair)
  • Kirstin Baker
  • Sarah Cardell (CEO)
  • Martin Coleman
  • Cynthia Dubin
  • Murdoch MacLennan
  • Erik Wilson (COO)

Advisors present

  • Jessica Lennard, Chief Strategy and External Affairs Officer
  • Chris Prevett, Interim General Counsel
  • Mike Walker, Chief Economic Adviser

Apologies

  • Lucy Robbins, Senior Director, People, Capability and Culture (PCC)
  • Michael Grenfell, Executive Director, Enforcement

CMA staff present

  • Will Hayter, Senior Director for the Digital Markets Unit
  • Jennifer Halliday, Senior Director, Advocacy and External Engagement1
  • Kate Bridge, Director of Executive Office, Security, and Property
  • Sukhinder Lalli, Legal Director, Governance, Compliance and Risk
  • Anthony Wright, Director, Communications [footnote 1]
  • Board Secretary (minutes)

Teams

The meeting was attended by the Markets, Remedies, Legal and Economic teams.

Introduction

1. Introduction

The Chair welcomed the Board members to the meeting.

Minutes

The Board approved the minutes from the meeting of the Board on 17 January 2024, with no changes.

3. Housebuilding Market Study

The Board discussed the outcomes of this market study which considered if competition issues are holding back housebuilding in Britain and whether there are elements in how the housebuilding market functions that are leading to poor outcomes for consumers. It approved the final report, including the recommendations, reform options and more fundamental levers for governments to consider. It decided that the CMA should not make a Market Investigation Reference into the housebuilding market in the UK.

4. Infant formula – Potential market study

The Board considered the proposal for a potential market study into infant formula and follow-on formula. It decided to launch a market study in late February into the supply of infant formula and follow-on formula in the UK.

5. Board effectiveness review

The Board reviewed the recent external evaluation of the effectiveness of the Board and its committees. It agreed a plan to onboard the expected new members and to incorporate the findings in its approach.

6. AOB

The Chair thanked the Board for the meeting.

  1. JH and AW joined the meeting for items 2 and 3.